Dr. Rouillard co-founded Biodiscovery LLC (previous name of Arbor Biosciences) in 2006 after spending time as a research investigator in Dr. Gulari’s lab at the University of Michigan. He has a vast amount of experience in developing molecular biology technologies, custom DNA microarray synthesizers, devices for embedded molecular biology processes, and bioinformatics pipelines which are at the foundation of technologies provided by Arbor Biosciences. He earned his PhD at University Pierre and Marie Curie, Paris and has collaborated with thought leaders in genetics and synthetic biology to deliver innovative solutions for complex research questions.
Erdogan co-founded Biodiscovery LLC (parent of Arbor Biosciences) in 2006 with Dr. Jean Marie Rouillard based on research done in his laboratories at the University of Michigan, and served as the managing partner until acquisition by Chiral Technologies. After working for 41 years as a professor of Chemical Engineering at the University of Michigan, he is now serving at Arbor Biosciences full time as Director of Operations. His research interests include DNA synthesis, microfluidic systems for single cell studies, and sustainable energy solutions. He has a BSE degree from Roberts College in Turkey and a Ph.D in Chemical Engineering from California Institute of Technology.
Linda joined Arbor Biosciences in 2019 as the Lead Product Scientist for myTags and cytogenomics. As a member of the Arbor Biosciences product management team, she is dedicated to addressing client needs for synthetic fluorescent probes used in FISH applications, from custom probe design to application based protocols. Linda brings to the myTags team an extensive background in the research arena utilizing in situ hybridization technology in pursuing the molecular drivers of development and regeneration in the zebrafish retina. Following her undergraduate at Central Michigan University Linda completed her MS at the University of Michigan. During off hours Linda volunteers her free time with her registered therapy dog Kipper sharing the human-animal bond with those in need of support in the greater Ann Arbor area. Otherwise you will find her wetting a fishing line in a northern Michigan stream or lake…
Brian has 20+ years of molecular biology research experience and joined the Arbor team in 2017 to provide support for customized targeted NGS applications. Previously, Brian spent nearly a decade leading a research project as a scientist with the USDA on how antibiotics affect the virulence of multidrug-resistant Salmonella. Brian’s education includes: post-doctoral research focused on studying genetic factors in cattle associated with resistance and susceptibility to bovine spongiform encephalitis at the National Animal Disease Center; a Ph.D. from UC Berkeley for investigating the phylogenetic and evolutionary relationships among strains of the human bacterial pathogen Chlamydia trachomatis; and a B.S. in Biochemistry and Biophysics from Rensselaer Polytechnic Institute. In his spare time, Brian enjoys cooking, going for walks with his dog, and bad puns.
Alison joined Arbor Biosciences in 2014 as Product Manager for myBaits hybridization capture kits, and was promoted to Director of Genomics in 2019. She has helped guide the significant expansion of Arbor’s NGS portfolio, focusing on specialty custom and predesigned targeted sequencing products and NGS services that leverage Arbor’s novel oligo synthesis technology. Alison performed her doctoral research with the McMaster University Ancient DNA Centre, studying ancient pathogen DNA using NGS targeted enrichment. Prior to that, she completed a B.A. in Biology and Archaeology at Boston University. Outside of work, Alison enjoys life in Ann Arbor with her family and dogs.
Evelyn joined Arbor Biosciences as a product development scientist in 2015 to apply her expertise in protein design and engineering for industrial and academic applications to the development of the myTXTL line of cell-free protein expression kits. In her current position as Division Manager for Synthetic Biology, she leads myTXTL product development and R&D operations, coordinates manufacturing of standard and customized kits, and markets the myTXTL product line. Prior to this role, Eggenstein completed her Ph.D. in Prof. Arne Skerra`s laboratory at the Technical University Munich, Germany, where she focused on the construction of Anticalin fusion proteins for therapy and diagnostics. After moving to the Detroit area, Eggenstein pursued her passion for protein science and joined Arbor Biosciences to develop and market the all-E. coli cell-free myTXTL platform. This has allowed Arbor Biosciences to become a provider of comprehensive solutions in the synthetic biology market starting from DNA synthesis to protein expression. Evelyn received a B.S. and M.S. in molecular biotechnology from Technical University Munich, and holds a patent on a collection of muteins of a1m lipocalin and method of production thereof.
Jake specializes in design and evaluation of molecular tools for targeted sequencing, and is passionate about matching Arbor’s clients’ research needs with innovative, cost-effective technologies. Before joining Arbor Biosciences in 2014, he performed graduate work in zooarchaeology and paleogenetics at Indiana University (B.S.) and the University of Utah (M.S.). Jake earned his Ph.D. from McMaster University under the mentorship of Prof. Hendrik Poinar, where he focused on Pleistocene elephantid phylogeography using ancient DNA techniques.
Jen joined the Arbor Biosciences team in 2019 as the Lead Product Scientist for the myReads NGS services division. For her doctoral research, completed in 2018, she studied how plague pandemics such as the Black Death affected the genetics of both the human host and the pathogen, Yersinia pestis. During her time at the McMaster Ancient DNA Centre, she worked on a plethora of other projects focused on a variety of species involving challenging samples with degraded DNA, which gave her a tool-set for experimental planning and solving laboratory problems. Through this experience, Jen developed a passion for improving and troubleshooting next-generation sequencing methods. She completed a B.A. in Anthropology and a B.Sc.in Chemistry at the University of Pittsburgh. When she’s not mulling over a new project, you can find Jen cuddling with her elderly beagle, Toby.
Ben joined Arbor Biosciences in 2015 to develop new products for synthetic biology and NGS applications. He has over 15 years’ research experience in molecular biology, including DNA/RNA design, synthesis and purification, CRISPR, cell-free systems, and DNA sequencing. Ben received his Ph.D. in microbiology and immunology from the University of Colorado where he studied the replication of poliovirus RNA in HeLa cell-free extracts. He went on to do a post-doc at a vaccine company where he designed and manufactured novel viral particles to serve as adjuvants in new and existing vaccines. Since being hired, he has been involved in improving production and developing novel products for almost every product line at Arbor. In addition to research and development activities, Ben is also the product manager for myLib DNA oligo pools, specializing in various life sciences applications.
Wanessa joined Arbor Biosciences in the latter half of 2018 as the first official member of the Sales Department. She holds B.S. degrees in both Psychology and Horticulture and earned her Ph.D. in Cell and Molecular Biology from Michigan State University, as part of the Plant Research Laboratories department. Following her academic career and before joining Arbor Biosciences, she has worked in various roles ranging from both inside and outside sales at some of the industry leaders in life sciences and genomics to running NGS sequencing at a core facility. When she is not trying to build up her sales team and its infrastructure, she can be found making and sculpting cakes, taking photos and enjoying time with her cats, dogs and her family.